Bellevue Group’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
Bellevue Group's ANGO Position: Q1 2019 in Review
Bellevue Group held its AngioDynamics (ANGO) position steady in Q1 2019 at 75,700 shares worth $1.73M. The position accounts for 0.1% of the portfolio, ranked #113.
Bellevue Group first reported a position in ANGO in Q1 2016 and has held it in 13 quarters since. The position peaked at $2.28M in Q3 2016. 178 funds tracked by Wall St. Rank hold ANGO as of Q1 2019.
- Bellevue Group held 75,700 shares of AngioDynamics worth $1.73M as of Q1 2019.
- Bellevue Group left its AngioDynamics share count unchanged in Q1 2019.
- AngioDynamics made up 0.1% of Bellevue Group's portfolio in Q1 2019, its #113 holding.
- Bellevue Group first reported a position in AngioDynamics in Q1 2016 and has held it in 13 quarters since.
- Bellevue Group's AngioDynamics position peaked at $2.28M in Q3 2016.
- 178 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2019.
Based on Bellevue Group's 13F filing for Q1 2019, filed 15 May 2019.